- Home
- XTLB vs ELSE Comparison
XTLB vs ELSE Comparison
Compare XTLB & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- ELSE
- Stock Information
- Founded
- XTLB 1993
- ELSE 1968
- Country
- XTLB Israel
- ELSE United States
- Employees
- XTLB N/A
- ELSE N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- ELSE Industrial Machinery/Components
- Sector
- XTLB Health Care
- ELSE Industrials
- Exchange
- XTLB Nasdaq
- ELSE Nasdaq
- Market Cap
- XTLB 15.6M
- ELSE 13.2M
- IPO Year
- XTLB 2005
- ELSE N/A
- Fundamental
- Price
- XTLB $2.36
- ELSE $3.90
- Analyst Decision
- XTLB
- ELSE
- Analyst Count
- XTLB 0
- ELSE 0
- Target Price
- XTLB N/A
- ELSE N/A
- AVG Volume (30 Days)
- XTLB 5.4K
- ELSE 2.2K
- Earning Date
- XTLB 11-20-2024
- ELSE 11-12-2024
- Dividend Yield
- XTLB N/A
- ELSE N/A
- EPS Growth
- XTLB N/A
- ELSE N/A
- EPS
- XTLB N/A
- ELSE 0.06
- Revenue
- XTLB N/A
- ELSE $8,834,000.00
- Revenue This Year
- XTLB N/A
- ELSE N/A
- Revenue Next Year
- XTLB N/A
- ELSE N/A
- P/E Ratio
- XTLB N/A
- ELSE $63.66
- Revenue Growth
- XTLB N/A
- ELSE 3.78
- 52 Week Low
- XTLB $0.75
- ELSE $3.65
- 52 Week High
- XTLB $4.99
- ELSE $4.40
- Technical
- Relative Strength Index (RSI)
- XTLB 40.17
- ELSE 46.18
- Support Level
- XTLB $2.25
- ELSE $3.91
- Resistance Level
- XTLB $2.56
- ELSE $4.05
- Average True Range (ATR)
- XTLB 0.10
- ELSE 0.03
- MACD
- XTLB -0.01
- ELSE -0.01
- Stochastic Oscillator
- XTLB 32.35
- ELSE 0.00
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.